Daniel Jamieson

Daniel Jamieson has worked in various roles in the biotechnology and pharmaceutical industries since 2010. Daniel began their career as a Bioinformatics Scientist at Merck in 2010, followed by a PhD at the University of Manchester from 2010 to 2013. In 2012, they worked as a Bioinformatician at Pfizer, before founding Biorelate Ltd. in 2013, where they served as CEO and Founder. In 2020, they joined the Early Career Advisory Panel at the Biochemical Society.

Daniel Jamieson has a comprehensive educational background. Daniel began their studies in 2005 at the University of Southampton, where they earned a Bachelor of Science (BSc) in Biology. Daniel then attended the University of Leeds in 2009-2010, earning an MRes in Bioinformatics and Computational Biology. In 2022, they will be attending Stanford University Graduate School of Business to pursue a degree in Influence and Negotiating Strategies with a focus on Economics. Daniel is also currently pursuing a Doctor of Philosophy (PhD) at The University of Manchester.